Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 12, 2020
Catalent announced that it has been approved by the FDA to produce commercial drug substance intermediate for AveXis’ spinal muscular atrophy gene therapy.
read more
Wednesday, August 12, 2020
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Catalent will expand its Argentinian site in Loma Hermosa, Buenos Aires.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more
Wednesday, August 05, 2020
Horizon Discovery announced TrueBinding has signed a set of commercial licenses for Horizon’s cGMP-compliant CHOSOURCE platform.
read more
Wednesday, August 05, 2020
The FDA proposed to include four bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug & Cosmetic Act.
read more
Piramal is providing Bolt with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing Phase 1/2 clinical study in cancer patients.
read more
Catalent will provide support for the development, manufacturing, and clinical supply of Editas Medicine’s current and future portfolio of in vivo CRISPR medicines and engineered cell medicines.
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
Avid Bioservices and Argonaut announced an to provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing.
read more
La Loma, Tlalnepantla, Mexico, Real Clean Distribuciones SA de CV is voluntarily recalling all lots four hand sanitizers it manufactured.
read more
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Abzena has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.
read more